Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV000153632 | SCV001370805 | pathogenic | Phenylketonuria | 2020-06-08 | reviewed by expert panel | curation | The c.809G>A (p.Arg270Lys) variant in PAH has been reported in multiple individuals with PAH deficiency (BH4 deficiency excluded). (PMID: 21871829, 23856132). This variant has an extremely low allele frequency (MAF=0.00016) in gnomAD. This variant has 11% residual PAH activity (PMID: 27620137). This variant was detected with multiple pathogenic variants: IVS10nt-11G>A (2 patients), L348V, S349P, R158Q, E390G, D415N (PMID: 21871829); and IVS4+5G>T (PMID: 23856132). Computational prediction tools and conservation analysis support a deleterious effect. In summary, this variant meets criteria to be classified as pathogenic for PAH. PAH-specific ACMG/AMP criteria applied: PM3_very-strong, PM2, PP4_Moderate, PP3, PS3_supporting. |
Eurofins Ntd Llc |
RCV000089105 | SCV000203180 | pathogenic | not provided | 2014-01-15 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000153632 | SCV000629217 | pathogenic | Phenylketonuria | 2024-11-05 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with lysine, which is basic and polar, at codon 270 of the PAH protein (p.Arg270Lys). This variant is present in population databases (rs62514950, gnomAD 0.009%). This missense change has been observed in individual(s) with phenylketonuria and hyperphenylalaninemia (PMID: 12173030, 20082265, 20187763, 23500595, 23856132). ClinVar contains an entry for this variant (Variation ID: 102846). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt PAH protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects PAH function (PMID: 16545551, 17935162, 25453233, 27620137). For these reasons, this variant has been classified as Pathogenic. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000153632 | SCV000696467 | pathogenic | Phenylketonuria | 2017-07-05 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000089105 | SCV001249179 | pathogenic | not provided | 2019-02-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000089105 | SCV002568584 | pathogenic | not provided | 2022-05-18 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 8528673, 11180595, 20082265, 20187763, 23856132, 29749107, 34828281, 17935162, 25750018, 27620137, 9598724, 7914195, 12173030, 16545551, 25453233, 23500595, 21871829, 26666653, 31355225, 32778825, 33465300) |
Baylor Genetics | RCV000153632 | SCV004209703 | pathogenic | Phenylketonuria | 2024-01-26 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000089105 | SCV004222249 | pathogenic | not provided | 2022-01-25 | criteria provided, single submitter | clinical testing | The variant has been reported in multiple individuals largely affected with classic PKU when another severe disease-causing variant is present on the other allele (PMID: 20082265 (2010), 21871829 (2011), 23856132 (2013), 26666653 (2015), 33465300 (2021)). Functional studies have shown that this variant causes severely reduced activity ranging from 2.1 to 11% of the wild-type activity (PMID: 16545551 (2006), 27620137 (2016)). Based on the available information, this variant is classified as pathogenic. |
De |
RCV000089105 | SCV000119712 | not provided | not provided | no assertion provided | not provided | ||
Natera, |
RCV000153632 | SCV002088644 | pathogenic | Phenylketonuria | 2020-11-06 | no assertion criteria provided | clinical testing |